Moderna wants to develop a specific booster dose for the Omicron variant

Moderna announced on Friday its intention to develop a specific booster dose for the new Omicron variant of Covid-19, detected in South Africa and deemed “of concern” by the WHO. “Moderna will rapidly develop a vaccine candidate for a booster dose specific to the Omicron variant,” the US company said in a statement.

Be “proactive in the face of the evolution of the virus”

The announcement is part of a strategy to work on specific booster doses for variants of concern, according to Moderna. “In 2020-2021, this has already included booster doses for the Delta and Beta variants,” said the laboratory, saying that it “has repeatedly demonstrated its ability to move new candidates to the stage of clinical trials in 60- 90 days “.

“From the start, we said that to fight the pandemic, it was imperative to be proactive in the face of the evolution of the virus,” said Moderna boss Stéphane Bancel, quoted in the press release. “The mutations of the Omicron variant are worrying and for several days we are moving as fast as possible to execute our strategy to fight against this variant”, he added.

The Omicron variant worries

Potentially highly contagious and mutually mutating, the new variant is causing global concern as it spreads outside South Africa, prompting the world to gradually close its borders to southern Africa. In Europe, Belgium has detected a first case. One case was reported in Hong Kong and one in Israel in a person returning from Malawi.

The German laboratory BioNTech, allied with Pfizer, said to study this new variant, and to await “at the latest in two weeks” of first results of studies which will make it possible to determine if it is able to escape the vaccine protection. It will take “several weeks” to understand the level of transmissibility and virulence of the new variant, the WHO spokesperson said on Friday. For the European Medicines Agency (EMA), it is “premature” to plan an adaptation of the vaccines to the Omicron variant.

Source From: Europe1

Share this article:

Leave a Reply

most popular